|
| Squamous Carcinoma |
| Etiology |
• Most closely associated with cigarette smoking of all lung cancers • Radiation, air pollution and genetic predisposition may also play a
role |
| Pathogenesis |
• BPDE (catabolite of benzo[a]pyrene in cigarette smoke) binds p53
mutational hot spots in lung carcinoma • p53 mutation affects cell replication and centromere replication • Sequence of changes from squamous metaplasia to dysplasia to carcinoma in
situ and then invasive carcinoma seen. |
| Epidemiology |
• Accounts for up to half of all lung
cancers. • Up to 10% of long term cigarette smokers develop |
| Clinical |
• Central location associated with cough and hemoptysis • Weight loss and dyspnea • Staging dependent on extent of disease ranging from I (confined to the
lung with >2 cm distance from hilum and pleura) to IV (metastatic disease)
• Metastatic disease to lymph nodes, brain, liver and adrenal glands • Surgical treatment is preferred; many patients have insufficient pulmonary
reserve for surgery; radiation an alternative • Overall five year survival 10-15% |
| General Gross Description |
• Usually arises from a major bronchus resulting in a central rather than
a peripheral location • Gray white hard granular neoplasm • Central cavitation common in large cancers • Uninvolved lung may often show emphysema or other smoking related
pathology |
| General Micro Description |
• Composed of cells with large irregular nuclei • Coarse nuclear chromatin with large nucleoli • Cells arranged in sheets • May make keratin pearls • Intercellular bridges considered diagnostic |
| Reference |
• Cotran RS, Kumar V, Robbins SL: Robbins Pathologic Basis of Disease. 5th edition. Philadelphia, W.B. Saunders, 1994, pp. 720-25.
|